Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $5,553 - $7,120
-645 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $5,527 - $8,185
645 New
645 $6,000
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $32,845 - $53,070
-4,045 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$6.69 - $13.45 $16,725 - $33,625
2,500 Added 161.81%
4,045 $41.2 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $6,170 - $10,130
945 Added 157.5%
1,545 $14.2 Million
Q3 2019

Nov 13, 2019

BUY
$6.16 - $9.6 $3,696 - $5,760
600 New
600 $4,000
Q2 2019

Aug 16, 2019

SELL
$8.12 - $15.72 $4,871 - $9,432
-600 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$15.58 - $20.01 $9,348 - $12,006
600 New
600 $0

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Advisory Alpha, LLC Portfolio

Follow Advisory Alpha, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.